发明名称 |
APTAMER-BASED TARGETED CHEMOIMMUNO THERAPY |
摘要 |
PURPOSE: A target-directed drug delivery system and a chemoimmunotherapy using the same are provided to effectively treat cancer. CONSTITUTION: A delivery system comprises: a biocompatible polymer carrier; a first nucleic acid molecule which is linked to the biocompatible polymer by covalent bond; a nucleic acid molecule ligand having a complementary sequence of the first nucleic acid molecule and a targeting sequence specifically binding to target cells or tissues; and a cargo linked to the ligand. The biocompatible polymer carrier has a dendrimer structure. The first nucleic acid molecule is immunostimulatory oligonucleotide of single strand. A pharmaceutical composition for promoting immunity contains the delivery system as an active ingredient.
|
申请公布号 |
KR20110127995(A) |
申请公布日期 |
2011.11.28 |
申请号 |
KR20100047567 |
申请日期 |
2010.05.20 |
申请人 |
GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY |
发明人 |
JON, SANG YONG;LEE, IN HYUN |
分类号 |
A61K9/32;A61K47/30;A61P35/00;A61P37/00 |
主分类号 |
A61K9/32 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|